EUVIMEDEUVIMED entdecken
Crossref

Automated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates

Weijian Ye, Junqi Hu, Zhiqiang Tan, Junjie Wei, Boyu Liu, Huiyi Wei, Wenqing Ran, Siqi Zhang, Kuan Hu iD, Steven H Liang iD, Ming-Rong Zhang iD, Hao Xu und 1 weitere

Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4133-4143

DOI: 10.1021/acs.molpharmaceut.6c00177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.07.2026. Verfasst von Weijian Ye und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Hauptthemen laut MEDLINE: Phenylalanine, Boron Compounds, Fluorine Radioisotopes, Radiopharmaceuticals. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Shanghai Key Laboratory of Molecular Imaging, Guangzhou Science and Technology Program key projects, Guangdong Provincial Key Laboratory of Research on Emergency in TCM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical efficacy of [10B]borono-l-phenylalanine ([10B]BPA)-mediated Boron Neutron Capture Therapy (BNCT) relies heavily on accurate patient stratification using the companion diagnostic tracer 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA). However, widespread clinical deployment is currently hindered by the limited production capacity and low molar activity of traditional electrophilic synthesis. To address this unmet need, we established a fully automated, GMP-compliant radiosynthesis of [18F]FBPA using a spirocyclic iodonium ylide (SCIDY) precursor on a commercial module. This optimized protocol delivered clinical-grade [18F]FBPA with a decay-corrected radiochemical yield of 15.5% ± 6.3% and a high molar activity of 75.9 ± 20.0 GBq/μmol. In vivo evaluation in subcutaneous xenografts showed high specificity for LAT1-positive tumors. Furthermore, in orthotopic C6 glioma and CAL27 tongue squamous cell carcinoma models, the tracer demonstrated effective blood-brain barrier penetration and good contrast, achieving Tumor-to-Normal (T/N) ratios of ∼ 3.3. Translational pharmacokinetic studies in nonhuman primates revealed rapid renal clearance and low background accumulation in critical head-and-neck organs, with a favorable effective dose of 0.012 mSv/MBq. This study presents a robust, clinical-ready strategy for producing high-molar-activity [18F]FBPA, bridging the gap between advanced radiochemistry and precise BNCT treatment planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylalanineBoron CompoundsFluorine RadioisotopesRadiopharmaceuticalsAnimalsBoron Neutron Capture TherapyHumansRatsMiceCell Line, TumorTissue DistributionFemalePositron-Emission TomographyXenograft Model Antitumor AssaysMice, SCID

Stichwörter der Autor:innen

Boron Neutron Capture TherapyPositron Emission TomographySCIDY RadiolabelingTumor Imaging[18F]FBPA

Substanzen

PhenylalanineBoron Compounds4-borono-2-fluorophenylalanineFluorine RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Nuclear Medicine, T…
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing100050, China.
  • Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd, Atlanta, Georgia30322, United States.
  • Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba263-8555, Japan.
  • The Guangzhou Key Laboratory of Basic and Translational Research on Chronic Diseases, Jinan University, Guangzhou510630, China.

ORCID-Profile: Kuan Hu, Steven H Liang, Ming-Rong Zhang, Lu Wang

Förderung

  • Shanghai Key Laboratory of Molecular Imaging
  • Guangzhou Science and Technology Program key projects
  • Guangdong Provincial Key Laboratory of Research on Emergency in TCM
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Ye, W., Hu, J., Tan, Z., Wei, J., Liu, B., Wei, H., Ran, W., Zhang, S., Hu, K., Liang, S. H., Zhang, M. R., Xu, H., & Wang, L. (2026). Automated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates. Molecular Pharmaceutics, 23(8), 4133-4143. https://doi.org/10.1021/acs.molpharmaceut.6c00177

Vancouver

Ye W, Hu J, Tan Z, Wei J, Liu B, Wei H, et al. Automated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates. Molecular Pharmaceutics. 2026;23(8):4133-4143. doi:10.1021/acs.molpharmaceut.6c00177

BibTeX
@article{Ye2026,
  author = {Ye, Weijian and Hu, Junqi and Tan, Zhiqiang and Wei, Junjie and Liu, Boyu and Wei, Huiyi and Ran, Wenqing and Zhang, Siqi and Hu, Kuan and Liang, Steven H and Zhang, Ming-Rong and Xu, Hao and Wang, Lu},
  title = {Automated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {8},
  pages = {4133--4143},
  doi = {10.1021/acs.molpharmaceut.6c00177}
}
Kostenlos starten →